Blueberries Medical Corp.
BBM
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.85% | 35.75% | -41.33% | -31.25% | -14.90% |
| Total Depreciation and Amortization | -50.74% | -28.97% | -8.46% | -12.64% | -45.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 195.50% | 77.78% | 56.63% | -45.31% | -59.22% |
| Change in Net Operating Assets | 129.02% | 306.28% | -4,414.29% | -8.33% | -300.86% |
| Cash from Operations | 56.43% | 68.40% | -53.72% | -64.67% | -81.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 98.38% | 98.22% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -102.40% | -102.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 25.00% | 0.00% | 0.00% | 99.89% | 99.91% |
| Issuance of Common Stock | -99.62% | -99.62% | -- | -47.04% | -47.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -61.64% | -78.61% | 55,160.00% | 71.58% | 75.64% |
| Foreign Exchange rate Adjustments | 34.32% | -2.71% | 21.11% | 118.29% | 132.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.36% | 43.24% | 93.61% | 32.87% | -73.59% |